214 related articles for article (PubMed ID: 37525698)
21. [Mixed connective tissue disease--etiology, pathogenesis, clinical significance, treatment].
Zdrojewicz Z; Budzyń-Kozioł E; Puławska J
Postepy Hig Med Dosw; 1999; 53(5):751-66. PubMed ID: 10645148
[TBL] [Abstract][Full Text] [Related]
22. Scleroderma overlap syndromes.
Jablonska S; Blaszczyk M
Adv Exp Med Biol; 1999; 455():85-92. PubMed ID: 10599327
[TBL] [Abstract][Full Text] [Related]
23. The diagnosis and classification of mixed connective tissue disease.
Tani C; Carli L; Vagnani S; Talarico R; Baldini C; Mosca M; Bombardieri S
J Autoimmun; 2014; 48-49():46-9. PubMed ID: 24461387
[TBL] [Abstract][Full Text] [Related]
24. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients.
Lundberg I; Hedfors E
J Rheumatol; 1991 Oct; 18(10):1511-9. PubMed ID: 1765975
[TBL] [Abstract][Full Text] [Related]
25. Facts and controversies in mixed connective tissue disease.
Martínez-Barrio J; Valor L; López-Longo FJ
Med Clin (Barc); 2018 Jan; 150(1):26-32. PubMed ID: 28864092
[TBL] [Abstract][Full Text] [Related]
26. Evolution of diagnostic criteria and new insights into clinical testing in mixed connective tissue disease; anti-survival motor neuron complex antibody as a novel marker of severity of the disease.
Kubo S; Tanaka Y
Immunol Med; 2024 Jun; 47(2):52-57. PubMed ID: 38597289
[TBL] [Abstract][Full Text] [Related]
27. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse.
Amigues JM; Cantagrel A; Abbal M; Mazieres B
J Rheumatol; 1996 Dec; 23(12):2055-62. PubMed ID: 8970041
[TBL] [Abstract][Full Text] [Related]
28. [The Sharp syndrome ("mixed connective tissue disease")].
Rosenthal M
Schweiz Med Wochenschr; 1976 Jan; 106(5):129-34. PubMed ID: 1082643
[TBL] [Abstract][Full Text] [Related]
29. Antibodies in Aseptic Meningitis of Connective Tissue Disorder: A Case Report.
Ravichandran S; Kumar J; Chandrasekaran ND; Irfan S; A S
Cureus; 2024 May; 16(5):e60762. PubMed ID: 38903288
[TBL] [Abstract][Full Text] [Related]
30. Interstitial lung disease in patients with mixed connective tissue disease: pilot study on predictors of lung involvement.
Narula N; Narula T; Mira-Avendano I; Wang B; Abril A
Clin Exp Rheumatol; 2018; 36(4):648-651. PubMed ID: 29745875
[TBL] [Abstract][Full Text] [Related]
31. A Rare Case of Mixed Connective Tissue Disease (MCTD) with Intricate Features of Lupus, Polymyositis and Rheumatoid Arthritis Presenting with Severe Myositis.
S L; Tony K; Raghupathy ; V S; Malepati B
J Clin Diagn Res; 2015 Mar; 9(3):OD05-7. PubMed ID: 25954655
[TBL] [Abstract][Full Text] [Related]
32. Lupus Cerebritis as a Rare Neuropsychiatric Manifestation of Systemic Lupus Erythematosus.
Leitao AR; Jain MS; Luvsannyam E; Jayswal V; Tiesenga F
Cureus; 2022 May; 14(5):e24973. PubMed ID: 35698669
[TBL] [Abstract][Full Text] [Related]
33. [Clinical analysis of 12 cases of mixed connective tissue disease-associated trigeminal neuropathy].
Gao XJ; Li YH; Zhang XW; Chen S; Liu YY
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(12):938-941. PubMed ID: 32234170
[No Abstract] [Full Text] [Related]
34. Scurfy Mice Develop Features of Connective Tissue Disease Overlap Syndrome and Mixed Connective Tissue Disease in the Absence of Regulatory T Cells.
Yilmaz OK; Haeberle S; Zhang M; Fritzler MJ; Enk AH; Hadaschik EN
Front Immunol; 2019; 10():881. PubMed ID: 31068947
[TBL] [Abstract][Full Text] [Related]
35. Predominance of IgM anti-U1RNP antibodies in patients with systemic lupus erythematosus.
Vlachoyiannopoulos PG; Guialis A; Tzioufas G; Moutsopoulos HM
Br J Rheumatol; 1996 Jun; 35(6):534-41. PubMed ID: 8670573
[TBL] [Abstract][Full Text] [Related]
36. [Clinical analysis of 79 pulmonary arterial hypertension cases from 1892 connective tissue disease patients].
Lei YX; Zhang X; Cui Y; Dong GF; Luo RQ
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(41):2934-7. PubMed ID: 20137654
[TBL] [Abstract][Full Text] [Related]
37. Blotting patterns of IgG anti-(U1)RNP antibodies in mixed connective tissue disease.
Ghirardello A; Doria A; Vesco P; Vaccaro E; Bernardi C; Catani C; Fagiolo U; Gambari PF
Rheumatol Int; 1996; 16(4):145-50. PubMed ID: 8961378
[TBL] [Abstract][Full Text] [Related]
38. Basophils and IgE contribute to mixed connective tissue disease development.
Lamri Y; Vibhushan S; Pacreau E; Boedec E; Saidoune F; Mailleux A; Crestani B; Blank U; Benhamou M; Papo T; Daugas E; Sacré K; Charles N
J Allergy Clin Immunol; 2021 Apr; 147(4):1478-1489.e11. PubMed ID: 33338538
[TBL] [Abstract][Full Text] [Related]
39. "To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity.
Cappelli S; Bellando Randone S; Martinović D; Tamas MM; Pasalić K; Allanore Y; Mosca M; Talarico R; Opris D; Kiss CG; Tausche AK; Cardarelli S; Riccieri V; Koneva O; Cuomo G; Becker MO; Sulli A; Guiducci S; Radić M; Bombardieri S; Aringer M; Cozzi F; Valesini G; Ananyeva L; Valentini G; Riemekasten G; Cutolo M; Ionescu R; Czirják L; Damjanov N; Rednic S; Matucci Cerinic M
Semin Arthritis Rheum; 2012 Feb; 41(4):589-98. PubMed ID: 21959290
[TBL] [Abstract][Full Text] [Related]
40. Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease.
Mesa A; Somarelli JA; Wu W; Martinez L; Blom MB; Greidinger EL; Herrera RJ
Lupus; 2013 Nov; 22(13):1371-81. PubMed ID: 24158973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
